Toe transfer
ProcedureToe-to-hand transfer
NCT Number: NCT06487676
Toe transfers are perceived to have changed the landscape of the injured hand over the last half century, yet there are limited validated data that unequivocally support the functional role of toe transfers after traumatic digital amputation. There also remain unanswered questions about what factors critically influence functional outcomes, be it sensory recovery, grip strength or other modality. Furthermore, the use of validated patient reported outcome measures (PROMs) in large series of toe transfers with long term follow up, is lacking.
Looking for future studies?
Notify MeAll sexes
Observational
Finger amputations are associated with profound impacts on physical, socio-economic, vocational and mental well-being. Thumb amputations account for the greatest burden of disability globally amongst hand trauma.
The multi-centre FRANCHISE study and a recent large prospective multi-centre study have demonstrated that finger replantation outperforms equivalent amputations in nearly all digits at all levels, except for the little finger. However, one crucial question in hand surgery is whether toe transfers can provide a similar functional benefit to replantation.
Finger amputations are frequently not replantable even with timely access to specialized reconstructive care. A review of replantation in the USA found that of 3,417 digital amputations, only 631 replantations were attempted (18%), and of these 30% failed. Therefore nearly 90% of patients with finger amputations will ultimately live without the amputated digit.
Microvascular toe-to-hand transfer, first described in the 1960s, has a success rate close to 100% in high volume centres. There are few validated data that support the functional benefits of toe transfer, with the majority of outcome studies focusing on operative survival rates, physical measurements such as grip strength, or employ unvalidated scales and self-created questionnaires. More data, in larger more representative populations, using validated PROMs, is required.
Here, we aim to demonstrate using PROMS that the role of toe transfers has equivalent or improved functional benefits, with comparison to finger replantation. Additionally, this study aims to identify physical factors that have the greatest influence on patient reported outcomes. This may answer fundamental questions regarding optimum strategies for the design of toe transfers.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Toe-to-hand transfer
Finger or thumb replantation after amputation
Other names: Finger or thumb replantation
Time frame: Single time-point, on average 22 years after surgery
Validated Hand function patient reported outcome measured. 0-100. Higher is better
Time frame: Single time-point, on average 22 years after surgery
Short Form 36 Quality of Life. 0-100. Higher is better
Time frame: Single time-point, on average 22 years after surgery
Validated foot function Patient reported outcome measure. 0-100. Lower is better
Time frame: Longitudinal. 3 timepoints: 1 day before surgery, 1 day after surgery, and on average 22 years after surgery
Subjective evaluation of toe transfer appearance using a Visual Analogue Scale, not validated
Time frame: Single time-point, on average 22 years after surgery
Total active range of motion of digit. Measured in degrees per digit
Time frame: Single time-point, on average 22 years after surgery
Measured with hand dynamometer. Measured in kilograms.
Time frame: Single time-point, on average 22 years after surgery
Measured with discriminator device. Two point discrimination measured in millimetres
Chang Gung Memorial Hospital
Other
Long Term Follow up of Toe-to-hand Transfers: Validated Patient Reported Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04776837
Biliary Tract Cancer, Biliary Tract Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT05556239
Atrophy, Behavior
Copenhagen, Denmark
View Trial DetailsNCT05486923
Adverse Effects, Glioma
Beijing, Beijing Municipality, China
View Trial DetailsNCT06571201
Behavior, Health Behavior
Kristianstad, Sweden
View Trial Details